Overview

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome

Status:
Completed
Trial end date:
2007-07-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of teduglutide compared with placebo in subjects with parenteral nutrition (PN)-dependent short bowel syndrome (SBS).
Phase:
Phase 3
Details
Lead Sponsor:
Shire
Treatments:
Teduglutide